Updates in IDH-Wildtype Glioblastoma

被引：0

作者：

Jawad M. Melhem

Jay Detsky

Mary Jane Lim-Fat

James R. Perry

机构：

[1] Sunnybrook Health Sciences Centre,Division of Neurology, Department of Medicine, Faculty of Medicine

[2] University of Toronto,Department of Radiation Oncology

[3] Odette Cancer Centre,undefined

[4] Sunnybrook Health Sciences Centre,undefined

来源：

Neurotherapeutics | 2022年 / 19卷

关键词：

Glioblastoma; IDH-wildtype; Targeted therapy; Precision medicine; Clinical trials;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Glioblastoma is the most aggressive primary brain tumor with a poor prognosis. The 2021 WHO CNS5 classification has further stressed the importance of molecular signatures in diagnosis although therapeutic breakthroughs are still lacking. In this review article, updates on the current and novel therapies in IDH-wildtype GBM will be discussed.

引用

页码：1705 / 1723

页数：18

共 50 条

[21] Glioblastoma, IDH-wildtype - a new association with IgM paraproteinaemic neuropathy?
Lewis, Dana
Colchester, Nancy
Duncombe, Andrew
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 164 - 165
[22] The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study
Andres Ramos-Fresnedo
Michael W. Pullen
Carlos Perez-Vega
Ricardo A. Domingo
Oluwaseun O. Akinduro
Joao P. Almeida
Paola Suarez-Meade
Lina Marenco-Hillembrand
Mark E. Jentoft
Bernard R. Bendok
Daniel M. Trifiletti
Kaisorn L. Chaichana
Alyx B. Porter
Alfredo Quiñones-Hinojosa
Terence C. Burns
Sani H. Kizilbash
Erik H. Middlebrooks
Wendy J. Sherman
Journal of Neuro-Oncology, 2022, 157 : 177 - 185
[23] Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?
Lewis, Dana M.
Colchester, Nancy T. H.
Allen, David
Nicoll, James A. R.
Katifi, Haider A.
Duncombe, Andrew S.
CASE REPORTS IN NEUROLOGY, 2022, 14 (01) : 213 - 222
[24] Differential Role of Hyperglycemia on Survival in IDH-wildtype Glioblastoma Subclasses
Liu, Elisa
Vasudevaraja, Varshini
Sviderskiy, Vladislav
Feng, Yang
Tran, Ivy
Serrano, Jonathan
Cordova, Christine
Kurz, Sylvia
Golfinos, John
Sulman, Erik
Placantonakis, Dimitris
Possemato, Richard
Snuderl, Matija
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 440 - 440
[25] CLINICAL OUTCOMES OF MOLECULAR GLIOBLASTOMA IDH-WILDTYPE: A RETROSPECTIVE STUDY
Patil, Nikunj
Pareek, Vibhay
Mutua, Florence
Dube, Sheen
Shankar, Jai
Sinha, Namita
Kakumanu, Saranya
RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S59 - S59
[26] Comment on "The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study"
Stoyanov, George S.
JOURNAL OF NEURO-ONCOLOGY, 2022, 157 (03) : 573 - 574
[27] Molecular profiling of long-term IDH-wildtype glioblastoma survivors
Burgenske, Danielle M.
Yang, Jie
Decker, Paul A.
Kollmeyer, Thomas M.
Kosel, Matthew L.
Mladek, Ann C.
Caron, Alissa A.
Vaubel, Rachael A.
Gupta, Shiv K.
Kitange, Gaspar J.
Sicotte, Hugues
Youland, Ryan S.
Remonde, Dioval
Voss, Jesse S.
Fritcher, Emily G. Barr
Kolsky, Kathryn L.
Ida, Cristiane M.
Meyer, Fredric B.
Lachance, Daniel H.
Parney, Ian J.
Kipp, Benjamin R.
Giannini, Caterina
Sulman, Erik P.
Jenkins, Robert B.
Eckel-Passow, Jeanette E.
Sarkaria, Jann N.
NEURO-ONCOLOGY, 2019, 21 (11) : 1458 - 1469
[28] Survival impact of incidental subventricular zone irradiation in IDH-wildtype glioblastoma
Hallaert, Giorgio
Pinson, Harry
Van den Broecke, Caroline
Sweldens, Caroline
Van Roost, Dirk
Kalala, Jean-Pierre
Boterberg, Tom
ACTA ONCOLOGICA, 2021, 60 (05) : 613 - 619
[29] Immunophenotypic Profile of Adult Glioblastoma IDH-Wildtype Microenvironment: A Cohort Study
Asioli, Sofia
Gatto, Lidia
Vardy, Uri
Agostinelli, Claudio
Di Nunno, Vincenzo
Righi, Simona
Tosoni, Alicia
Ambrosi, Francesca
Bartolini, Stefania
Giannini, Caterina
Franceschi, Enrico
CANCERS, 2024, 16 (22)
[30] Comment on "The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study"
George S. Stoyanov
Journal of Neuro-Oncology, 2022, 157 : 573 - 574

← 1 2 3 4 5 →